TL;DR: Aetna, a CVS Health company, maintains its non-coverage position on the Menaflex device under CPB 0786, modified December 3, 2025. HCPCS code G0428 is explicitly not covered for any indication. Here's what billing teams need to know.
Aetna's Menaflex coverage policy under CPB 0786 classifies the Menaflex collagen meniscal implant as experimental, investigational, or unproven for all indications — including medial meniscus repair and reinforcement. The single HCPCS code tied to this device, G0428, is listed as not covered across the full range of relevant ICD-10 diagnosis codes. If your orthopedic or sports medicine practice bills Aetna for collagen meniscus implant procedures, this policy update is a direct claim denial risk you need to address before December 3, 2025.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Menaflex — CPB 0786 |
| Policy Code | CPB 0786 |
| Change Type | Modified |
| Effective Date | December 3, 2025 |
| Impact Level | High |
| Specialties Affected | Orthopedic Surgery, Sports Medicine, Orthopedic Billing Teams |
| Key Action | Flag G0428 in your charge capture system as non-covered under Aetna and update patient financial counseling accordingly |
Aetna Menaflex Coverage Criteria and Medical Necessity Requirements 2025
The Aetna Menaflex coverage policy under CPB 0786 is unambiguous: there are no covered indications. Aetna does not consider the Menaflex device — also known historically as the Collagen Meniscal Implant (CMI) or the Collagen Scaffold device — medically necessary for any patient population or clinical scenario.
Aetna's position is that the evidence for this device is insufficient to support medical necessity. That applies to the primary intended use — repair and reinforcement of the medial meniscus of the knee — and every other potential indication. There is no pathway to coverage, no exceptions list, and no prior authorization route that gets this device covered under an Aetna plan.
The practical implication for reimbursement is straightforward: G0428 billed to Aetna will be denied. It does not matter how the procedure is documented or what diagnosis code supports the clinical picture. The coverage policy blocks reimbursement at the procedure level.
If your practice has been billing G0428 to Aetna patients — or discussing this procedure as a treatment option without flagging the coverage issue — you need to change that process now. Patient responsibility conversations need to happen before the procedure, not after the claim comes back denied.
Aetna Menaflex Exclusions and Non-Covered Indications
Aetna classifies the Menaflex device as experimental, investigational, or unproven. That's the strongest non-coverage language Aetna uses, and it has specific consequences for your billing and appeals processes.
When Aetna labels a procedure "experimental or investigational," the denial reason code on the remittance will reflect that classification. Standard medical necessity appeals typically won't reverse these denials. The bar for overturning an experimental designation requires new published clinical evidence — not a physician attestation or a Letter of Medical Necessity.
The CPB 0786 Aetna system entry lists this non-coverage status across the full diagnostic spectrum tied to knee conditions — osteoarthritis, internal derangement, meniscal tears, pain, osteochondritis dissecans, and acute knee injuries. That breadth matters. Aetna isn't carving out a specific subset of patients. The non-coverage applies whether the patient has a traumatic medial meniscus tear (S83.211–S83.249) or chronic knee pain (M25.561–M25.569) or anything in between.
This is similar in structure to how Aetna handles other orthopedic devices and biologics where the clinical trial data hasn't matured into peer-reviewed consensus. Don't expect the coverage position to shift without a substantive change in the evidence base.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Medial meniscus repair and reinforcement | Not Covered — Experimental | G0428, S83.211–S83.249 | No covered pathway exists |
| All other knee indications | Not Covered — Experimental | G0428, M17.0–M17.9, M22–M25, M93.261–M93.269, S89.90x–S89.92x | Broad ICD-10 range — all denied |
There are no covered indications under CPB 0786. Every use case for G0428 billed to Aetna falls into the non-covered category.
Aetna Menaflex Billing Guidelines and Action Items 2025
The effective date is December 3, 2025. These actions should be completed before that date.
| # | Action Item |
|---|---|
| 1 | Flag G0428 in your charge capture system as non-covered under Aetna. Add a hard stop or alert so billing staff know this code will be denied before a claim goes out. A denied claim costs you time to work and risks write-off if the patient responsibility wasn't disclosed in advance. |
| 2 | Audit claims from the past 12 months for G0428 billed to Aetna. If you've submitted G0428 to Aetna and received payment, review those claims carefully. Experimental or investigational device denials sometimes surface on post-payment audit. Understand your exposure now. |
| 3 | Update your patient financial counseling workflow for any Menaflex procedure discussions. If an orthopedic surgeon is recommending the Menaflex device to an Aetna member, that patient needs a clear, documented conversation about non-coverage before consent. Get the financial counseling done and documented before the procedure is scheduled. |
| 4 | Do not pursue prior authorization for G0428 under Aetna. A prior auth request will not change the outcome. Aetna's coverage policy blocks this procedure at the policy level, not the utilization management level. Spending time on a PA request is wasted time. |
| 5 | Check your other payer contracts for Menaflex coverage status. Aetna is not the only payer with questions about this device. Review your Cigna Healthcare, UnitedHealthcare, and CMS policies for similar non-coverage language. The evidence gap that drives Aetna's position exists across all payers reviewing this device. |
| 6 | If your practice has significant orthopedic volume, loop in your compliance officer. The combination of a "experimental" designation, a broad ICD-10 code range, and past billing activity creates audit risk. Your compliance officer should know this policy exists and what your historical billing looks like. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Menaflex Under CPB 0786
Not Covered / Experimental HCPCS Codes
| Code | Type | Description | Coverage Status |
|---|---|---|---|
| G0428 | HCPCS | Collagen meniscus implant procedure for filling meniscal defects (e.g., CMI, Collagen Scaffold, Menaflex) | Not covered — experimental, investigational, or unproven for all listed indications |
There are no covered CPT codes associated with this policy. G0428 is the sole procedure code, and it carries a blanket non-covered status.
Key ICD-10-CM Diagnosis Codes
These are the diagnosis codes Aetna lists in CPB 0786 as part of the non-covered code set. Billing G0428 with any of these codes will result in a claim denial.
| Code | Description |
|---|---|
| M17.0 | Osteoarthritis of knee |
| M17.1 | Osteoarthritis of knee |
| M17.2 | Osteoarthritis of knee |
| M17.3 | Osteoarthritis of knee |
| M17.4 | Osteoarthritis of knee |
| M17.5 | Osteoarthritis of knee |
| M17.6 | Osteoarthritis of knee |
| M17.7 | Osteoarthritis of knee |
| M17.8 | Osteoarthritis of knee |
| M17.9 | Osteoarthritis of knee |
| M22.2x1–M23.92 / Q68.6 | Internal derangement of knee |
| M25.161–M25.169 / M25.861–M25.869 | Other specified disorders of knee joint |
| M25.261–M25.269 / M25.361–M25.369 | Other joint derangement of knee |
| M25.561 | Pain in knee |
| M25.562 | Pain in knee |
| M25.563 | Pain in knee |
| M25.564 | Pain in knee |
| M25.565 | Pain in knee |
| M25.566 | Pain in knee |
| M25.567 | Pain in knee |
| M25.568 | Pain in knee |
| M25.569 | Pain in knee |
| M93.261 | Osteochondritis dissecans, knee |
| M93.262 | Osteochondritis dissecans, knee |
| M93.263 | Osteochondritis dissecans, knee |
| M93.264 | Osteochondritis dissecans, knee |
| M93.265 | Osteochondritis dissecans, knee |
| M93.266 | Osteochondritis dissecans, knee |
| M93.267 | Osteochondritis dissecans, knee |
| M93.268 | Osteochondritis dissecans, knee |
| M93.269 | Osteochondritis dissecans, knee |
| S83.211–S83.249 | Tear of medial cartilage or meniscus of knee, current injury |
| S89.90x–S89.92x | Injury of knee |
The ICD-10 range here covers essentially the full spectrum of knee pathology that would lead a clinician to consider a meniscal implant. Aetna isn't leaving any diagnostic backdoor open. That's intentional — and it tells you the non-coverage position is firm.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.